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Computer simulationSeveral bioactive peptides exert their biological function by interacting with cellular membranes. Structural
data on their location inside lipid bilayers are thus essential for a detailed understanding of their mechanism
of action. We propose here a combined approach in which ﬂuorescence spectroscopy and molecular
dynamics (MD) simulations were applied to investigate the mechanism of membrane perturbation by the
antimicrobial peptide PMAP-23. Fluorescence spectra, depth-dependent quenching experiments, and
peptide-translocation assays were employed to determine the location of the peptide inside the membrane.
MD simulations were performed starting from a random mixture of water, lipids and peptide, and following
the spontaneous self-assembly of the bilayer. Both experimental and theoretical data indicated a peptide
location just below the polar headgroups of the membrane, with an orientation essentially parallel to the
bilayer plane. These ﬁndings, together with experimental results on peptide-induced leakage from large and
giant vesicles, lipid ﬂip-ﬂop and peptide exchange between vesicles, support a mechanism of action
consistent with the “carpet” model. Furthermore, the atomic detail provided by the simulations suggested
the occurrence of an additional, more speciﬁc and novel mechanism of bilayer destabilization by PMAP-23,
involving the unusual insertion of charged side chains into the hydrophobic core of the membrane.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) constitute a fundamental compo-
nent of the innate immune defense [1,2], and have multiple functions,
including immunomodulatory and chemotactic roles [3]. However,
their mechanism of antibacterial activity is mainly based on associa-
tion to the pathogen plasma membrane and perturbation of its
permeability [2,4–7]. This is in marked contrast to traditional
antibiotics, which usually act by attacking a speciﬁc receptor or
enzymatic target, and it should signiﬁcantly hinder the development
of bacterial resistance to AMPs [8], since it is difﬁcult for a microbe to
change the phospholipid organization of its membrane. For this
reason, AMPs are intensely investigated as a possible solution to the
global problem of the insurgence of bacteria resistant to available
antibiotic drugs [9,10]. Furthermore they also display interesting
anticancer activity [11]. Even though several AMPs are already
undergoing clinical trials [12–15], several issues need to be solved+39 06 72594328.
ll rights reserved.before they can ﬁnd a widespread clinical application as systemic
drugs, in particular regarding their toxicity, potential immunogenicity
and rapid proteolytic degradation [14,16].
A detailed understanding of the mechanism of membrane
destabilization by antimicrobial peptides is of paramount importance
to design new analogues or peptide-mimicking molecules with
improved activity, selectivity, and bioavailability properties, but such
a molecular insight is still lacking. This is probably related to the
difﬁculties involved in the application of the most powerful structural
techniques (NMR and X-ray diffraction) to study peptide–membrane
interactions [17]. Even though interesting progress is being made in
the application of these techniques to AMPs [18–20], alternative
approaches for gaining structural information in membranes would
be desirable. Optical spectroscopies, and particularly ﬂuorescence
techniques, can be easily applied to model membrane systems, and
even to live cells. They can provide a wealth of information on
peptide–membrane interactions, such as peptide afﬁnity for the
membrane phase, its location and orientation in the bilayer, and its
effects on membrane structure and integrity [21–27]. However, these
low-resolution structural data are hardly sufﬁcient for a clear
structural interpretation of the pore-formation mechanism. On the
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level data on the structure and dynamics of peptide–membrane
systems [28,29,30,31], but they need a validation by comparisons with
experimental data. We report here a combined approach, in which
ﬂuorescence spectroscopy experiments and MD simulations comple-
ment each other in the characterization of the interaction of PMAP-23
with lipid membranes.
PMAP-23 (RIIDLLWRVRRPQKPKFVTVWVR) [32] belongs to the
group of cathelicidins, one of the major AMP families in mammals
[33–35]. It shows a potent and broad spectrum antimicrobial activity
against bacteria and fungi (due to membrane permeabilization), and
it is not toxic to eukaryotic cells up to concentrations 100 times
higher than those needed for bactericidal activity [36,37]. Its structure
in membrane-mimicking environments has been determined by CD
and NMR studies [38], and it appears to be an amphipathic helix,
except for a central region, comprising the two Pro residues, which is
disordered [39].
In order to obtain position-speciﬁc information from ﬂuorescence
spectroscopy experiments, two single-tryptophan analogues of PMAP-
23 were synthesized, inwhich one of the two natural Trp residues was
substituted by Phe. In the following, these analogues are indicated as
W7 and W21, where the number indicates the position of the
unmodiﬁed Trp.
Our results provide a clear picture of PMAP-23 location inside
the bilayer and new insights in its membrane-destabilizing activity,
including a possible functional role for the central non-helical
segment, and a novel mechanism of bilayer perturbation involving
the insertion of charged side chains into the hydrophobic
membrane core.
2. Materials and methods
2.1. Materials
Phospholipids were purchased from Avanti Polar Lipids (Alabaster,
AL), while carboxyﬂuorescein, Triton X-100, Sephadex G-50 and
trypsin were purchased from Sigma (St. Louis, MO). Spectroscopic
grade chloroform and methanol (C. Erba, Milan, Italy) were used.
2.2. Peptide synthesis
The peptides were synthesized using the solid-phase method with
Fmoc [40]. Fmoc-protected peptides were deprotected and cleaved by
incubation with a mixture of triﬂuoroacetic acid, phenol, water,
thioanisole, and 1, 2-ethandithiol (82.5:5:5:5:2.5, v/v) for 3 h at room
temperature. The synthetic peptides were puriﬁed by RP-HPLC on
Shimadzu LC-6AD and Shimadzu LC-10Avp systems using an ODS
column (4.6×250 mm). The puriﬁed peptides were shown to be
homogeneous (N98%) by analytical HPLC. The molecular weight of all
synthetic peptides was conﬁrmed using Kratos Kompact matrix-
assisted laser desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS, Shimadzu, Japan).
2.3. Liposome preparation
Large unilamellar vesicles were prepared as previously described
[22]. All liposomes were formed by egg phosphatidylcholine (ePC)
and egg phosphatidylglycerol (ePG) (2:1 molar ratio). This lipid
mixture has been widely used to mimic bacterial membranes; even
though PC is not a bacterial lipid, this composition reproduces the
content of zwitterionic and anionic lipids in the cytoplasmic
membrane of bacteria. Lipids were hydrated in a 10 mM phosphate
buffer (pH 7.4), containing 140 mMNaCl and 0.1 mM EDTA. Total lipid
concentration is reported.
Liposomes containing the ﬂuorescent lipid 1-palmitoyl-2-[6-((7-
nitrobenz-2-oxa-1,3-diazol-4-yl)amino)caproyl]-L-α-phosphatidyl-choline (C6-NBD-PC) were prepared essentially as described in [26]. A
5% (mol/mol) ratio was used between labeled and total lipids.
Chemical quenching by sodium dithionite [41,42] was obtained with a
1500:1 dithionite:NBD molar ratio.
The degree of labeling of nitroxide-containing lipids (1-palmitoyl-
2-stearoyl(n-doxyl)-sn-glycero-3-phosphocholine, with n=5, 7, 10,
12, 14, 16, and 1,2-diacyl-sn-glycero-3-phosphotempocholine),
employed for depth-dependent quenching studies, was determined
by double integration of electron paramagnetic resonance (EPR)
spectra [43]. nitroxide-labeled liposomes were produced by adding
the labeled lipids to the initial chloroform solution (7% molar
fraction). Spin label content was controlled directly on the ﬁnal
liposomes by double integration of the EPR spectra of an aliquot of the
liposomes dissolved in isopropanol. All liposome preparations con-
tained the same amount of spin labels, within a 10% error. The
ﬂuorescent peptide analogs were added to the different nitroxide-
labeled liposomes (at a lipid concentration of 0.2 mM) and to a
reference unlabeled liposome solution, and steady-state ﬂuorescence
intensities were determined after a 20 min equilibration period. The
reported values are the average of triplicate experiments.
Giant unilamellar vesicles (GUVs) were prepared by the
electroformation method, as previously described [44], in a 0.3 M
sucrose, 3 μM carboxyﬂuorescein (CF) solution. A 1.5 V (peak to
peak), 10 Hz potential was applied to the electroformation
chamber, for 1 h, and then switched to 4 V, 4 Hz for 15 min to
favor detachment of GUVs from the electrode. The solution
contained in the electroformation chamber was gently removed,
and diluted 300 times in buffer (pH7.4, 10 mM phosphate, 140 mM
NaCl, 0.1 mM EDTA). The lipid composition of GUVs was 66% ePC,
33% ePG and 1% rhodamine-labeled phosphatidylethanolamine
(Rho-PE). Silanized glass slides were employed during ﬂuorescence
imaging. The GUVs content and the lipid membrane could be
observed independently by imaging the green CF ﬂuorescence and
the red Rho-PE ﬂuorescence.
2.4. Leakage mechanism
Peptide-induced membrane permeability was determined by
measuring the fractional release of CF entrapped inside liposomes,
as already reported [22]. In order to determine the leakagemechanism
(graded or “all or none”), the quenching efﬁciency of the carboxy-
ﬂuorescein still entrapped inside vesicles after partial peptide-
induced leakage was measured. Different peptide concentrations (10
to 15 μM) were incubated with ePC/ePG vesicles (lipid concentration
200 μM), containing 30 mM CF for different times, in order to obtain
various levels of partial leakage. The peptide was then digested by
trypsin addition (ﬁnal concentration 50 μg/mL), and this immediately
stopped the leakage process (within the few seconds needed for
sample mixing), indicating that complete peptide digestion had been
achieved, and that PMAP-23 proteolytic fragments did not retain any
membrane activity. The CF released until trypsin addition was
separated from the vesicles by gel permeation chromatography. The
quenching efﬁciency (E) of the CF still entrapped inside vesicles was
determined by comparing the ﬂuorescence intensity of intact vesicles
(F) with that measured after the same vesicles were disrupted by
adding the detergent Triton X-100,1 mM (F0): E=1−F/F0. In order to
determine the dependence of the quenching efﬁciency on the CF
concentration entrapped inside vesicles, liposomes (50 μM lipid
concentration) with different known internal CF concentrations
(between 5 and 30 mM) were prepared, and the quenching efﬁciency
determined as described above.
2.5. Fluorescence spectroscopy
Steady-state ﬂuorescence experiments were carried out on a SPEX
Fluoromax 2 ﬂuorimeter (Edison, NJ). Temperature was controlled to
Fig. 1. Fraction of overall liposome contents released after addition of different peptide
concentrations. Leakage was determined by the variation of carboxyﬂuorescein
emission intensity following release from the liposome's internal volume. Liposome
composition ePC/ePG 2:1 (mol/mol). Lipid concentration 0.2 mM. Diamonds PMAP-23;
squares W7; circles W21.
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excited at 280 nm.
2.6. Water–membrane partition
The peptide fraction associated to the lipid bilayers of liposomes
(xmembrane) was determined by the variation of ﬂuorescence intensity
observed following peptide partition from the water to the membrane
phase, according to the following equation
F λð Þ = xmembraneFmembrane λð Þ + 1− xmembraneð ÞFwater λð Þ
where Fmembrane and Fwater are the ﬂuorescence intensities measured
when the peptide is in one phase only.
The average wavelength of the peptide emission spectrum was
calculated according to the following equation:
hλi =
R
λ  F λð Þdλ
R
F λð Þdλ
where the integral was extended from 320 to 420 nm.
2.7. Peptide exchange between vesicles
Experiments of peptide exchange between different vesicles were
carried out by incubating the peptide (5 μM) with vesicles labeled
with the ﬂuorescent lipid N-NBD-PE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3benzoxadiazol-4-yl), which
quenches the intrinsic peptide tryptophan ﬂuorescence by acting as
an energy-transfer acceptor (lipid 200 μM). Peptide exchange
between vesicles was monitored by measuring the decrease in energy
transfer following addition of unlabeled vesicles (ﬁnal concentration
800 μM). Fluorescence intensity was recorded with an excitation
wavelength of 280 nm.
2.8. Lipid ﬂip-ﬂop
Vesicles labeled in the inner layer with C6-NBD-PC (lipid
concentration 200 μM) were incubated for 20 min with different
concentrations of PMAP-23, to cause peptide-induced lipid ﬂip-ﬂop.
Successively, the peptide was digested by incubating with 2 μM of
trypsin for 10 min, to remove any peptide-induced membrane pores.
The amount of C6-NBD-PC translocated across the membrane bilayer
was determined by adding sodium dithionite, and following NBD
reduction by the decrease of ﬂuorescence intensity. NBD ﬂuorescence
was excited at 460 nm and monitored at 520 nm. Results are reported
as ﬂip-ﬂop fractions, where complete ﬂip-ﬂop corresponds to the
attainment of an equilibrium distribution of labeled lipids in the two
membrane layers.
2.9. Molecular dynamics simulations
Molecular dynamics simulations were performed according to the
method proposed by Esteban-Martín and Salgado [45]. Brieﬂy, PMAP-
23 was initially shaped in a canonical α-helix, with extended side
chains, and positioned at the center of a cubic box with a side of
8.5 nm. 32 POPGmolecules (16 molecules for each of the two possible
chiralities of POPG) and 96 POPC molecules, with different conforma-
tions taken from equilibrated simulations of phospholipid bilayers
[46], and then 5026 water molecules were added randomly in the box.
Finally, 26 Na+ ions were introduced in substitution of 26 randomly
selectedwatermolecules, to ensure system neutrality. MD simulations
were performed with GROMACS 3.3, using ffgmx parameters [47]. The
simple point charge (SPC) model was used for water [48], and water
geometry was constrained with the SETTLE algorithm [49]. POPC and
POPG parameters were previously reported [50–52]. A Berendsenthermostat, with a coupling constant of 0.1 ps, was applied in all
simulations [53]. The reference temperature was set to 300 K, except
where stated otherwise. Pressure coupling was applied anisotropi-
cally, also employing the Berendsen scheme, with a time constant of
1.0 ps and a reference pressure of 1 bar. Bond lengths were
constrained with the LINCS algorithm [54]. Short-range electrostatics
and Lennard–Jones interactions were cut-off at 1.0 nm and long range
electrostatic interactions were calculated by using the particle mesh
Ewald algorithm [55,56]. Simulations were run with a 4 fs timestep,
removing fast hydrogen vibrations according to Feenstra et al. [57].
The systemwas energy-minimized and a ﬁrst 100 ps equilibration MD
run was performed with position restraining on the peptide.
Molecular graphics were obtained with the program VMD [58].
3. Results
3.1. Membrane-perturbing activity
The membrane-perturbing activity of PMAP-23 and its analogues
was determined by measuring the peptide-induced leakage of the
ﬂuorescent tracer carboxyﬂuorescein (CF) entrapped inside phospho-
lipid vesicles (Fig. 1). Both single-tryptophan PMAP-23 analogues
exhibited a membrane-perturbing activity comparable to the natural
peptide, in agreement with previous ﬁndings showing that their
antimicrobial activity on several different bacterial strains was
comparable [39]. Therefore, the two analogues W7 and W21 could
be employed as reliable models of the behavior of PMAP-23.
Giant unilamellar vesicles (GUVs), whose size is in the micro-
meters range, allowed direct visualization of the peptide-induced
leakage process by ﬂuorescence microscopy experiments (Fig. 2). The
lipidmembrane and the aqueous contents of the vesicles were imaged
simultaneously by taking advantage of the green ﬂuorescence of
entrapped carboxyﬂuorescein and of the red emission of a rhodamine-
labeled lipid, respectively. PMAP-23 was able to cause the leakage of
vesicle contents, as indicated by the disappearance of CF emission
caused by its diffusion in the extravesicular volume. However, no
observable changes took place in the membrane, even after complete
release of GUV contents, indicating that PMAP-23 causes membrane
leakage by forming pores rather than by causing membrane
micellization.
Another important question regarding the release mechanism is
whether it takes place as an “all-or-none” or as a graded process. In the
Fig. 3. Panel A: Concentration dependence of self-quenching efﬁciency for CF entrapped
inside ePC/ePG vesicles. Panel B: CF self-quenching efﬁciency after partial PMAP-23
induced leakage. Peptide-induced leakage from ePC/ePG vesicles containing 30 mM CF
was stopped after the release of different fractions of CF contents by digesting PMAP-23
with trypsin. The continuous curve represents the constant quenching value expected
for an all-or-none leakage mechanism, while the broken curve shows the quenching
efﬁciency expected in the case of graded release (according to the concentration
dependence of the self-quenching efﬁciency determined from the data in panel A).
Fig. 2. Fluorescence microscopy images of PMAP-23 induced leakage from a giant
unilamellar vesicle. Panel A: ﬂuorescence emission from carboxyﬂuorescein molecules
entrapped inside the GUV, before and after peptide addition. The ﬂuorophore was
completely released. Panel B: ﬂuorescence emission from rhodamine-labeled phos-
pholipids located in the GUV bilayer. The membrane remained intact even after
complete release of the GUV contents. The vesicle diameter is about 20 μm.
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present in the sample at a given time during the leakage kinetics, since
the time needed for the leakage of liposome contents is shorter than
the lifetime of peptide-induced pores. By contrast, in the case of a
graded leakage, partially emptied vesicles are present [59]. The two
possibilities can be discriminated by measuring the carboxyﬂuor-
escein quenching efﬁciency after partial peptide-induced leakage has
taken place [60,61], thanks to the fact that self quenching of CF is due
to dye aggregation, and therefore it is strongly concentration
dependent [62]. Fig. 3A shows the CF self-quenching efﬁciency
measured for different CF concentration entrapped inside ePC/ePG
vesicles. The quenching efﬁciency E was satisfactorily described by a
phenomenological Hill sigmoidal curve deﬁned by the equation
E =
KCð Þn
1 + KCð Þn
with n=1.5 and K=76.2 M−1, in agreement with previous reports on
similar systems [60–62].
In the case of an all-or-none mechanism, at any time during the
leakage process each vesicle is either completely empty or it contains
the same CF concentration originally entrapped inside the liposomes.
Therefore, the self-quenching efﬁciency of entrapped CF is always the
same, irrespective of the fraction of vesicles that have released their
contents. On the other hand, in a graded process, the CF concentration
inside the liposomes decreases during the leakage, causing a decrease
in the self-quenching efﬁciency of entrapped CF [60].
PMAP-23 was incubated with CF-containing liposomes for differ-
ent times, in order to obtain various levels of partial leakage. The
leakage process was stopped by digesting the peptide with trypsin
and the released CF was separated from the vesicles by gel permeation
chromatography. The self-quenching efﬁciency of the CF still
entrapped inside vesicles was always constant within experimentalerrors (Fig. 3B), demonstrating that the leakage process followed an
all-or-none mechanism.
3.2. Peptide-induced lipid ﬂip-ﬂop
In the absence of external perturbations the rate of spontaneous
translocation of lipids across the bilayer (lipid “ﬂip-ﬂop”) is so low
that several days are needed until an initially asymmetric membrane
attains a homogeneous lipid distribution in both layers. However,
manymembrane-perturbing agents cause a huge enhancement of this
rate, so that the ﬂip-ﬂop process can be completed even in a few
minutes [63].
In order to check whether PMAP-23 induces lipid translocation
across the two leaﬂets of the membrane, vesicles labeled with the
ﬂuorescent lipid C6-NBD-PC (1-palmitoyl-2-[6-((7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino)caproyl]-L-α-phosphatidylcholine) in the
inner leaﬂet of the membrane only were incubated with different
concentrations of PMAP-23. The peptide was then digested by trypsin
addition, and the fraction of labeled lipids translocated to the external
layer was determined by measuring their quenching by sodium
Fig. 4. Fraction of lipids ﬂip-ﬂopped across the membrane during 20 min of incubation
with different concentrations of PMAP-23.
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observed (Fig. 4). Interestingly, this phenomenon exhibited a
dependence on peptide concentration very similar to that observed
in the leakage curves (Fig. 1), suggesting that the two phenomena
are coupled.
3.3. Water–membrane peptide partition
We next investigated peptide partition between the water and
membrane phase of PMAP-23 and its analogues, by measuring theFig. 5. Panel A: Water-membrane partition curves of PMAP-23, W7, and W21. Panel B:
Variation in the average wavelength of the emission spectra of the three analogues
caused by membrane binding. PMAP-23 (diamonds), W7 (squares) and W21 (circles).
Liposome composition ePC/ePG 2:1 (mol/mol). Peptide concentration 10 μM.changes in peptide ﬂuorescence caused by titration of a peptide
solution with phospholipid vesicles. As shown in Fig. 5, the three
analogues exhibited a comparable afﬁnity for membranes, with a
complete binding at lipid concentrations higher than 150 μM. Also the
spectral shift caused by membrane association was similar for the
three peptides (Fig. 5B), suggesting that the twoTrp residues of PMAP-
23 sensed a similar environment when the peptide was bound to
the membrane.
3.4. Peptide location in the bilayer
Amore precise determination of peptide location in themembrane
could be obtained by depth-dependent quenching experiments [65].
Fig. 6 shows the peptide-ﬂuorescence quenching caused by associa-
tion to liposomes containing lipids labeled at different depths along
the acyl chain with a nitroxide group, which acted as a quencher of
peptide tryptophan ﬂuorescence. Surprisingly, the quenching proﬁle
was rather wide and ill deﬁned, as compared to similar experiments
performed on other peptides [26,27,66–69], particularly in the case of
Trp7. However, the quenching curves for both single-ﬂuorophore
analogues show a maximum slightly below 1 nm from the
bilayer center.
3.5. Peptide exchange between vesicles
The ability of PMAP-23 to exchange between different vesicles was
assessed by a method based on ﬂuorescence resonance energy
transfer (FRET). The peptide was added to vesicles labeled with the
ﬂuorescent lipid N-NBD-PE (1,2-Dioleoyl-sn-Glycero-3-phosphoetha-
nolamine-N-(7-nitro-2-1,3benzoxadiazol-4-yl), which can act as a
FRET acceptor for the intrinsic peptide tryptophan ﬂuorescence.
Peptide and lipid concentrations (5 μM and 200 μM, respectively)
were chosen to ensure complete peptide association to the vesicles.
After equilibration of the system, an excess of unlabeled vesicles (ﬁnal
concentration 800 μM) was added to the sample. A spectral change
was observed, which was completed within the few seconds needed
for mixing and acquisition: Trp ﬂuorescence increased and NBD
emission decreased (Fig. 7), indicating a reduced FRET efﬁciency
caused by peptide exchange between acceptor-labeled and unlabeled
vesicles. Under this respect it is worth mentioning that the time-scaleFig. 6. Depth-dependent quenching experiments. The ordinate values (“quenching
proﬁle”) represent values of F0/F−1, where F0 is the ﬂuorescence intensity of
peptides associated to unlabeled liposomes, and F is the emission intensity of the
peptide bound to vesicles labeled with quenching groups located at different distances
from the bilayer center. Peptide concentration 1 μM, lipid concentration 200 μM.
Squares: W7; circles: W21.
Fig. 8. FRET experiments on peptide translocation. Panel A: decrease in PMAP-23
ﬂuorescence (F) when NBD-labeled lipids, acting as FRET acceptors, were added to the
outer or to the inner leaﬂet of the liposomemembrane, with respect to the ﬂuorescence
of PMAP-23 associated to unlabeled vesicles (F0). Panel B: increase in NBD ﬂuorescence
(F) when the peptide was added to liposomes containing the ﬂuorescent lipid in the
outer or inner leaﬂet of themembrane, with respect to the ﬂuorescencemeasured in the
absence of PMAP-23 (F0). Data referring to outer layer labeled liposomes are
represented by circles, while those referring to inner layer labeled liposomes are
shown as diamonds. PMAP-23 concentration 1 μM, lipid concentration 200 μM.
Fig. 7. FRET experiment demonstrating the ability of PMAP-23 to exchange between
different vesicles. The continuous curve represents the emission spectrum (λexc.
280 nm) of a sample inwhich the peptide (5 μM)was added to ePC/ePG vesicles labeled
with C6-NBD-PC. The broken line is the spectrum of the same sample immediately after
addition of an excess of unlabeled vesicles. The decrease in FRET efﬁciency between Trp
residues and NBD, caused by the passage of PMAP from labeled to unlabeled vesicles, is
demonstrated by the increase in Trp ﬂuorescence (λmax. ∼350 nm) and the concomitant
decrease in NBD emission (λmax. ∼520 nm).
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magnitudes slower [70].
3.6. Peptide translocation across the bilayer
A FRET assay [26] was employed to determine whether the
peptide, when added to a vesicle suspension, would remain associated
to the outer layer of the liposomes or translocate across themembrane
to become distributed in the whole bilayer. An energy-transfer
acceptor for Trp ﬂuorescence was introduced in the liposomes as a
ﬂuorescent lipid (C6-NBD-PC). Two different types of vesicles were
prepared: outer layer labeled liposomes (OL), where the ﬂuorescent
probe was incorporated only in the outer layer by adding it to a vesicle
suspension after liposome formation and inner layer labeled lipo-
somes (IL), obtained by chemically quenching the label in the outer
layer of liposomes homogeneously labeled in both layers. The FRET
phenomenon has an inverse sixth power dependence on distance,
with a 50% quenching efﬁciency at an interprobe distance called the
Förster radius [71,72]. In the case of the Trp-NBD pair, this distance is
26 Å [21], whereas the thickness of the bilayer is approximately 40 Å
[73]. Since the ﬂuorophore of C6-NBD-PC is located in the region of the
polar headgroups [74–76], a peptide lying in the outer layer or a
peptide distributed in the whole bilayer would be quenched quite
differently. In the case of PMAP-23 a signiﬁcant energy transfer was
observed only with OL liposomes (Fig. 8), indicating that the peptide
did not translocate across the membrane, at least at the concentration
investigated. It is important to note that this assay can only be
performed under conditions in which lipid asymmetry is conserved,
and lipid ﬂip-ﬂop is negligible during the assay time. For this reason,
the experiment could only be performed at 1 μM PMAP-23
concentration, at which the peptide is not active (see above).
3.7. Molecular dynamics simulations
In order to further characterize PMAP-23 position in the bilayer,
molecular dynamics (MD) simulations were performed following a
novel minimum bias approach. Present day computational resources
allow simulation of large systems (such as those including a hydrated
lipid bilayer) for times in the 0.1–1 μs range. However, these trajectory
lengths are not sufﬁcient for a complete sampling of all possible
peptide arrangements in the relatively viscous environment of a
preformed membrane bilayer [28,77]. As a result, simulations ofpeptide interaction with lipid membranes can be inﬂuenced sig-
niﬁcantly by the starting conditions, being unable to ﬁnd the global
free energy minimum. Recently, an approach to overcome this
limitation based on the spontaneous self-assembly of lipid bilayers
has been proposed [45,78]. In this case, simulations starting from a
randommixture of lipids, water, and one peptide molecule lead to the
spontaneous formation of a bilayer membrane in a computationally
accessible time (10–100 ns). During this self-assembly process (which
involves intermediate steps where the lipid and water phase start to
separate long before an ordered bilayer is formed) the peptide is able
to position in the most favorable local environment, taking advantage
of the high ﬂuidity of the system. It is interesting to note that, at the
best of our knowledge, the present study is the ﬁrst case in which a
quantitative test of the MD results obtained with this approach is
attempted, taking advantage of our depth-dependent quenching
experiments, and of previously reported NMR and CD studies [38].
Two independent simulations were performed in order to test the
reliability of the results, with the peptide initially forced in a perfectα-
helical conformation, but with different initial random conﬁgurations
of water and lipids. In 100 ns of simulation a lipid bilayer formed in
both cases, although a rather stable water-ﬁlled pore was still present
(Fig. 9), as previously observed in all simulations of spontaneous
bilayer formation [78,79–81]. To facilitate elimination of bilayer
defects, the system was cycled repeatedly between 300 K and 375 K
(rising the temperature linearly in 2 ns, decreasing it in 50 ps, and
keeping it constant at 300 K for 950 ps). This annealing protocol did
not cause signiﬁcant modiﬁcations in peptide conformation or
position. After the water channel was eliminated (i.e. after 13 and
27 cycles in the two simulations), the trajectory was extended for
further 10 ns keeping the temperature at 300 K. All data analyses were
performed on these ﬁnal trajectory segments, which were deemed
equilibrated as judged from the root mean square positional
displacements of the peptide atoms, from the stability of the peptide
secondary structure, from the membrane thickness and molecular
surface area (data not shown), and from the density map of
phosphorus atoms and peptide backbone atoms (see below).
A representative frame of one of the two simulations is shown in
Fig. 10A, illustrating PMAP-23 position inside the bilayer; a very
similar arrangement was observed in both simulations. The peptide
Fig. 9. Bilayer formation during the MD simulation. Left, center and middle panels represent, respectively, the situation after the initial restrained simulation, after 100 ns of
unrestrained simulation, and at the end of the trajectory, after bilayer defects were removed with an annealing protocol. The density distribution graphs shown in the upper panels
indicate the position of water molecules (gray line), phospholipids (dashed line), peptide (black solid line) and phosphate groups (dotted line).
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polar and apolar regions. The positional distribution of the indole
moieties of both Trp residues was centered at about 1 nm from the
bilayer center (Fig. 10B), in agreement with the ﬂuorescence
experiments. The helical conformation of the peptide was substan-
tially maintained, but a signiﬁcant discontinuity was observed in
correspondence of the central segment (where the two Pro residues
are located), in agreement with previous NMR experiments in
detergent micelles [38]. In this conformation, the peptide side chainsFig. 10. Panel A: Representative structure at the end of one of the twoMD simulations. Water
yellow spheres. The peptide backbone is shown in grey, charged side chains in red, polar
distribution of the indole moieties of the twoTrp residues of PMAP-23 in the sameMD simula
C: Density map of the lipid phosphorus atoms (red) and of the peptide backbone atoms (bwere arranged in an amphiphilic orientation, but two of the charged
side chains (Arg10 and Lys14) were forced in the apolar side.
Interestingly, these side chains were inserted in the lipid core of the
membrane, and caused a signiﬁcant perturbation by forcing some
lipid polar heads and water molecules deep inside the bilayer (Fig.
10A). This perturbation was stably maintained for all the ﬁnal
segments of the trajectories, as demonstrated by the density map
calculated for the peptide backbone atoms and for the lipid
phosphorus atoms during the last 10 ns of the trajectories (Fig 10C).is represented in cyan, phospholipids in gray, and phospholipids' phosphorus atoms as
aminoacids in orange, apolar residues in blue, and prolines in green. Panel B: Density
tion, averaged over the trajectory segment after formation of a defect-free bilayer. Panel
lue) averaged over the last 10 ns of the trajectory.
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assessed by determining the order parameters of the palmitic chains
of the lipids with respect to the bilayer normal [82] during the last
10 ns of the trajectory. The average order parameter in the lipid leaﬂet
not containing PMAP-23 was 0.45 and 0.44 in the two simulations,
while the same parameter calculated in the membrane layer including
the peptide was signiﬁcantly reduced (0.32 and 0.29). Furthermore,
the average order parameter of the lipids whose polar heads where
drawn in the apolar region of the bilayer by association to the charged
side chains of Arg10 and Lys 14 was −0.02 and 0.15 in the two
simulations, demonstrating a speciﬁc disordering effect of these
peptide residues.
4. Discussion
Peptide–membrane interactions play a prominent role in many
biological processes, such as bilayer translocation by cell-penetrating
peptides [83], peptide-inducedmembrane fusion [84], ﬁbril formation
by amyloid peptides [85], and membrane destabilization by AMPs.
However, a thorough understanding of all these phenomena is still
elusive, mainly due to difﬁculties involved in the structural studies of
peptide–membrane systems. The determination of the structure of
membrane proteins is notoriously difﬁcult, since these molecules
rarely form crystals suitable for X-ray diffraction, and their incorpora-
tion in model membranes hinders high resolution structural studies
by multidimensional NMR techniques. As a consequence, membrane
proteins account for less than 2% of records included in the Protein
Data Bank [86]. Pores constituted by antimicrobial peptides present
even additional difﬁculties due to the intrinsic dynamical nature of
these systems. For instance, the ﬁrst determination by X-ray
diffraction of the electron density proﬁle of an AMP channel was
only recently reported, but the resolution was intrinsically limited by
the variability of the pore position within the periodic cell and by the
variability of atomic positions within the pore structure [20].
Molecular dynamics simulations can be applied to such systems,
and provide the positions of all atoms and their dynamical behavior.
However, due to the approximations involved in the computations,
they need to be validated by comparisons with experimental data to
be deemed reliable. To this end, we have compared MD results with
several ﬂuorescence spectroscopy experiments, which supplement
previously published NMR and CD data on peptide conformation [38].
Such a combined application of spectroscopic experiments and
computational data has previously proved valuable in our studies on
the solution structure of peptide foldamers [71,87–90] and on protein
dynamics [91–93], but its application to peptide–membrane interac-
tions has been very limited so far [94].
In the case of the antimicrobial peptide PMAP-23, our ﬂuorescence
data clearly indicated a peptide orientation essentially parallel to the
membrane plane, and an approximate location just below the polar
headgroups of the bilayer. The two Trp residues located at different
positions along the primary sequence exhibited comparable spectral
shifts as a consequence of membrane association. Since Trp emission
is strongly dependent on its insertion depth inside a membrane
[95,96], this ﬁnding suggests a similar location of the two residues in
the bilayer. Furthermore, depth-dependent quenching experiments
conﬁrmed that both Trp residues were located preferentially at about
1 nm from the bilayer center, i.e. at a depth corresponding
approximately to the interface between the polar headgroups region
and the hydrophobic core of the bilayer (Fig. 9). The depth of insertion
and orientation observed here for PMAP-23 are similar to those of
other AMPs of the same family, such as LL-37 [97,98]. In connection to
the depth-dependent quenching experiments, it is interesting to note
that the dependence of the quenching efﬁciency on the depth of the
quenching group was less peaked than those previously observed for
other peptides [26,27,66–69], particularly for Trp7. In order to
interpret this result, it is important to consider that the observedquenching proﬁle results from the convolution of the distribution of
depths populated both by the ﬂuorophore and by the quencher [66].
Therefore, the broad quenching proﬁle observed for PMAP-23 could
be attributed to two possible causes: the peptide might sample a wide
distribution of depths inside the bilayer [23], or, alternatively, peptide
binding could induce local disorder in the phospholipids, increasing
the width of the depth distribution sampled by the quenching
moieties. MD results clearly indicated the second effect as the
dominant one, as further discussed below.
Fluorescence data provided also further indications regarding the
distribution of PMAP-23 between the two leaﬂets of the membrane,
showing that it was not able to translocate across the bilayer, at least at
concentrations at which it was still not causing membrane leakage.
This is in contrast with the behavior of other, more hydrophobic AMPs,
such as trichogin, which form transmembrane pores and which can
distribute in both membrane layers even at concentrations at which
they are not active [26].
MD results were in excellent agreement with all the available
experimental evidences. In both trajectories, the helical character of
the peptide conformation was essentially retained, in agreement with
CD data showing that PMAP-23 is mostly helical when associated to
lipid membranes [38]. However, the helical structure was lost in the
central segment of the peptide comprising Pro 12 and 15, and this
allowed a much more amphiphilic arrangement of the side chains
than in the perfect helical structure which was used as the starting
conformation in our simulations. In this ﬁnal membrane-bound
conformation all the apolar residues pointed towards one side of the
helix, and most of the charged side chains were located on the
opposite side. An amphiphilic distribution of the side chains is a
common feature of helical [99] and non-helical AMPs [100], and
strongly favors their interactionwith themembrane surface. However,
an exception to the regular amphiphilic distribution of the side chains
in the conformation attained during the simulations was provided by
two charged residues (Arg10 and Lys14) located close to the central
kink, which pointed towards the apolar face of the peptide helix. All of
the main structural features of the conformation attained during the
simulations (helical character, with a break in the central segment,
and amphiphilic arrangement of the side chains with the exception of
Arg10 and Lys14, which point towards the apolar face) are in
agreement with the PMAP-23 structure previously determined by
NMR experiments in membrane-mimicking micelles [38].
In addition to peptide conformation, also its position in the bilayer
during the MD simulations was in good agreement with the available
experimental data: in both trajectories, the helix was oriented
essentially parallel to the membrane plane, and located just below
the region of the phosphate moieties, in conformity with the
ﬂuorescence data reported above. Overall, these ﬁndings support
the view that the self-assembling, minimum-bias simulative approach
employed in this study can be deemed a reliable method to determine
peptide structure inside phospholipid membranes.
More interestingly, the MD simulations allowed us to investigate
the effects of peptide binding on the lipid bilayer organization (at low
peptide to lipid ratios). When PMAP-23 was associated to the lipid
bilayer in our simulations, the side chains of Arg10 and Lys 14 became
deeply inserted into the hydrophobic core of the membrane. This
ﬁnding might seem surprising, since the transfer of charged groups
from a polar solvent (such as water) to an apolar environment (such
as the core of a lipid bilayer) is strongly unfavorable [101,102].
However, this side-chain arrangement appears to be imposed by the
peculiar features of PMAP-23: Arg10 takes part in a helical segment
comprising also Arg8 and Arg11, and it would be impossible for these
three charged side chains to point all towards the same side of the
helix. Similarly, Lys14 is strongly constrained, being located between
Pro12 and Pro15, which is then followed by another Lys residue.
Notwithstanding the forced imperfect amphiphlic arrangement of the
charged side chains, peptide association to the phospholipid bilayer is
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segments: the Wimley and White hydrophobicity scale for interfacial
peptide partitioning [103] predicts a free energy of water–membrane
partition of −5.6 and −4.7 kcal/mol for the PMAP-23 helical
segments 1–11 and 15–23, respectively. These values are more than
sufﬁcient to counterbalance the free energy cost related to the
insertion of Arg10 and Lys14: for these two residues, the Wimley and
White water–octanol hydrophobicity scale [103] predicts values of 1.8
and 2.8 kcal/mol, respectively, for membrane insertion, and similar
values are reported in the “biological” hydrophobicity scale of Hessa
et al. [104]. Furthermore, our simulations suggest that the high free
energy penalty associated with the dehydration of the charged side
chains was strongly reduced by local bilayer deformations, which
allowed the interaction of the Arg and Lys residues with lipid polar
headgroups and water molecules drawn inside the bilayer. This
ﬁnding is in agreement with other recent MD simulations, showing
that Lys and Arg side chains, when forced inside lipid bilayers, always
cause such local perturbations [77,101,105–111]. In addition, it had
been previously shown that salt-bridge formation (in our case
between the peptide side chains and the charged phosphatidylgly-
cerol headgroups) can reduce the free energy cost of desolvating
charged groups [112].
It is important to note that in our classical MD simulations the
protonation state of the charged groups was ﬁxed during the whole
trajectory. Therefore, it may be argued that the observed deformations
in the bilayer structure were due to the a priori assumption of a
charged state for the Lys and Arg side chains, evenwhen located inside
the hydrophobic lipid corewhere their pKamight change signiﬁcantly.
However, recent free energy calculations showed that Lys and Arg
residues remain protonated even when inserted at signiﬁcant depths
inside the membrane [101,108,109,111].
Interestingly, the local disorder caused in the lipid bilayer by the
insertion of two charged side chains provides also an explanation for
the ill-deﬁned depth-dependent quenching proﬁles observed for Trp7
of PMAP-23, which is located close to the lipid region disordered by
Arg10 and Lys 14 (Fig. 10).
Our ﬂuorescence microscopy experiments with giant vesicles have
shown that PMAP-23 causes the leakage of membrane contents with
the formation of pores, and this appears to be the mechanism of its
antimicrobial activity. It is worth to consider the possible implications
of the observed effects of PMAP-23 on the structure of the bilayer for
the mechanism of its membrane-perturbing activity, also in view of
other experimental evidences. Differentmodels were proposed for the
mechanism of pore formation by antimicrobial peptides [7], but
except for subtle differences, they fall essentially in two classes [113].
The “barrel-stave” model [114] predicts the formation of well deﬁned
pores by several peptide helices which aggregate in a transmembrane
orientation, like the staves in a barrel, with their hydrophilic face
lining the water-ﬁlled pore lumen, and the hydrophobic side oriented
towards the lipid membrane. A typical representative for AMPs acting
through this mechanism is the peptaibol alamethicin [23]. On the
other hand, in the alternative mechanism, commonly termed the
“carpet model” [4,8,115–117], peptides accumulate on the external
membrane surface (like a carpet), causing expansion of the outer layer
and a strain between the two leaﬂets of the bilayer. When a threshold
local concentration is reached, this strain is released through the
formation of local membrane defects, which could involve the
formation of toroidal pores, in which the lipid bilayer folds back
onto itself in a doughnut shape [118]. Several cationic AMPs appear to
act according to this model [4]. The observed location of PMAP-23 on
the membrane surface clearly points to the second mechanism of
membrane perturbation. This conclusion is further supported by the
correlation of peptide-induced membrane leakage with lipid translo-
cation (ﬂip-ﬂop), since the formation of local defects in the
membranes can promote the exchange of lipids between the two
membrane layers [63,116].The consensus view of the mechanism of membrane disruption
through this model is based on the effects of peptide insertion on the
surface tension of the external membrane layer [119]. However, our
MD results suggest an additional, more speciﬁc mechanism of bilayer
destabilization, involving the insertion of charged side chains into the
hydrophobic core of the membrane, while the peptide is lying at the
water–membrane interface. This mechanism has never been observed
before, and deﬁnitely it does not apply generally to helical cationic
AMPs, since a survey of about 50 Protein Data Bank structures of
antimicrobial peptides determined by NMR spectroscopy in mem-
brane-mimicking environments did not evidence any other peptide in
which a few charged side chains point decidedly towards the apolar
face of the helix. However, this does not exclude the possibility that the
membrane perturbation mechanism observed in the present study
might be of relevance also for other membrane-active peptides, in
addition to PMAP-23. For instance, a recent NMR study by Hong et al.
[120] indicated that Arg side chains of the β-hairpin antimicrobial
peptide protegrin-1, while inserted into the hydrophobic part of the
bilayer, are closely associated to the phosphate groups of membrane
phospholipids. A similar interaction has also beenproposed tomediate
the membrane translocation of cell-penetrating peptides [107].
During our simulations (which involved a single peptide), the
actual formation ofmembrane defects leading to the diffusion ofwater
from one side to the other of the bilayer, was not observed. However,
the perturbation induced by a single peptide chain was sufﬁcient to
cause water penetration deep inside the membrane. It can be
hypothesized that when several peptides accumulate on the bilayer
surface in close proximity, the cumulative effects of charged side
chains insertion in the bilayer on its structure could easily lead to the
formation of a local membrane defect, or pore. Such a cooperative
effect is supported by the observation that the carboxyﬂuorescein
leakage caused by PMAP-23 followed an all-or-none mechanism, in
which the liposomes remained full until a lesion formed and all their
contentswere rapidly released. Thisﬁnding is consistentwith the view
inwhich the perturbation causedby isolated PMAP-23molecules is not
sufﬁcient to cause leakage, and therefore a local accumulation of bound
peptide is needed for the formation of a membrane pore. This
conclusion is further supported by the observation that in our leakage
experiment a complete release of the contents of all liposomes was
obtained only at a boundpeptide to lipid ratio of 1/10 (Fig.1). Since the
area occupied by a peptide molecule can be estimated from our MD
structure to be around 400 Å2 and the area per lipid molecule is about
70 Å2 [121], this peptide/lipid ratio corresponds to an almost complete
coverage of the membrane surface.
In conclusion, a coupled approach employing ﬂuorescence experi-
ments and molecular dynamics simulations can be successfully used
to characterize the interaction of bioactive peptides with lipid
membranes. Fluorescent data are essential to validate the simulative
results, and the good agreement observed in the present study
between the computational and experimental data suggests that
determination of peptide location inside lipid bilayers by state of the
art simulative methods can be reliable. This opens the way for a new
understanding of the mechanism of action of AMPs, since MD
simulations provide a structural detail unattainable by any presently
available experimental method. In the case of PMAP-23, combined
experimental and simulative data support the carpet model for
mechanism of membrane perturbation, but indicate as well that this
peptide causes membrane destabilization also in a more speciﬁc way,
by introducing two charged side chains deep into the hydrophobic
membrane core. Further experiments are now underway on PMAP-23
analogues to conﬁrm this hypothesis.
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